3rd Quarter - Report
BIOMERIEUX for BIOMERIEUX
Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions related to H.R.8078, Sepsis Harm and Cost Reduction Act Discussions regarding H.R.2369, VALID Act of 2023 (Verifying Accurate Leading-edge IVCT Development Act) Discussions regarding H.R.2940, PASTEUR Act (Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023) Discussions related to H.R.2377, SALSA Act (Saving Access to Laboratory Services Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH BREWER | — |
| PAUL HARTMAN | 12/2015-1/2018-LA-Rep.Tim Murphy; 1/2018-1/2019-LA-Rep.Tom Garrett Jr.; 1/2019-3/2019-House Energy and Commerce Health Subcommittee; HHS Policy Advisor 3/2019-10/2019; 10/2019-8/2024-Policy Advisor Rep. Bob Latta |
| JOHN RICHTER | 2009-2014 -Office of Sen. Robert Casey; 2014-2017-0ffice of Congresswoman Michelle Lujan Grisham |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.